Cargando…

Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析

BACKGROUND AND OBJECTIVE: Da Vinci robotic surgery system is widely used in department of thoracic surgery. The aim of this study is to investigate the treatment outcome of stage Ⅰ non-small cell lung cancer (NSCLC) via da Vinci Surgical System. METHODS: Clinical date of 347 stage Ⅰ NSCLC patients,...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247004/
https://www.ncbi.nlm.nih.gov/pubmed/30454547
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.11.07
_version_ 1783372422872825856
collection PubMed
description BACKGROUND AND OBJECTIVE: Da Vinci robotic surgery system is widely used in department of thoracic surgery. The aim of this study is to investigate the treatment outcome of stage Ⅰ non-small cell lung cancer (NSCLC) via da Vinci Surgical System. METHODS: Clinical date of 347 stage Ⅰ NSCLC patients, who underwent lobectomy and systematic node dissection from Jan. 2012 to Dec. 2017, were reviewed. 134 patients underwent robot-assisted thoracic surgery (RATS) and 213 patients underwent video-assisted thoracic surgery (VATS). To compare perioperative outcome (blood lose, postoperative drainage, drainage time, postoperative hospital stay, number of the LN dissection) and analyze overall survival (OS), disease free survival (DFS) of the two groups and prognostic factors. RESULTS: The RATS group got less blood lose [(49±39 mL for RATS vs (202±239) mL for VATS, P < 0.05] and postoperative drainage [Day 1: (248±123) mL for RATS vs (350±213) mL for VATS; Day 2: (288±189) mL for RATS vs (338±189) mL for VATS, P < 0.05]. There were no significant difference for drainage time (10±5 for RATS vs 11±8 for VATS, P < 0.05) and postoperative hospital stay (13±6 for RATS vs 14±9 for VATS, P < 0.05) between the two groups. The RATS group harvested a more number of mean stations (5±2 for RATS vs 4±2 for VATS) and amounts (18±9 for RATS vs 11±8 for VATS) of the lymph nodes, P < 0.05. There was no statistically significant difference of OS between RATS and VATS group [1-year OS: 97.3% vs 96%; 3-year OS: 89.8% vs 83.1%; 5-year OS: 87.5 % vs 70.3%; overall survival time (mean): 61 months vs 59 months, P > 0.05]; corresponding there had a statistically significant difference of DFS between the two groups [1-year DFS: 93.7% vs 91.3%; 3-year DFS: 87.7% vs 68.4%; 5-year DFS: 87.7% vs 52.5%; disease free survival time (mean): 61 months vs 50 months, P < 0.05]. The univariate analysis found that the amounts of the lymph nodes dissection was the prognostic factor for OS and tumor diameter, surgical approach, stations and amounts of the lymph nodes dissection were respectively the prognostic factors for DFS. However, multivariate analysis found that there was not independently factors for OS, but the tumor diameter and surgical approach were independently associated with DFS. CONCLUSION: There was no significant difference about OS between the two groups, but the RATS got better DFS. RATS got more number of the LN dissection and less blood lose.
format Online
Article
Text
id pubmed-6247004
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-62470042018-12-05 Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Da Vinci robotic surgery system is widely used in department of thoracic surgery. The aim of this study is to investigate the treatment outcome of stage Ⅰ non-small cell lung cancer (NSCLC) via da Vinci Surgical System. METHODS: Clinical date of 347 stage Ⅰ NSCLC patients, who underwent lobectomy and systematic node dissection from Jan. 2012 to Dec. 2017, were reviewed. 134 patients underwent robot-assisted thoracic surgery (RATS) and 213 patients underwent video-assisted thoracic surgery (VATS). To compare perioperative outcome (blood lose, postoperative drainage, drainage time, postoperative hospital stay, number of the LN dissection) and analyze overall survival (OS), disease free survival (DFS) of the two groups and prognostic factors. RESULTS: The RATS group got less blood lose [(49±39 mL for RATS vs (202±239) mL for VATS, P < 0.05] and postoperative drainage [Day 1: (248±123) mL for RATS vs (350±213) mL for VATS; Day 2: (288±189) mL for RATS vs (338±189) mL for VATS, P < 0.05]. There were no significant difference for drainage time (10±5 for RATS vs 11±8 for VATS, P < 0.05) and postoperative hospital stay (13±6 for RATS vs 14±9 for VATS, P < 0.05) between the two groups. The RATS group harvested a more number of mean stations (5±2 for RATS vs 4±2 for VATS) and amounts (18±9 for RATS vs 11±8 for VATS) of the lymph nodes, P < 0.05. There was no statistically significant difference of OS between RATS and VATS group [1-year OS: 97.3% vs 96%; 3-year OS: 89.8% vs 83.1%; 5-year OS: 87.5 % vs 70.3%; overall survival time (mean): 61 months vs 59 months, P > 0.05]; corresponding there had a statistically significant difference of DFS between the two groups [1-year DFS: 93.7% vs 91.3%; 3-year DFS: 87.7% vs 68.4%; 5-year DFS: 87.7% vs 52.5%; disease free survival time (mean): 61 months vs 50 months, P < 0.05]. The univariate analysis found that the amounts of the lymph nodes dissection was the prognostic factor for OS and tumor diameter, surgical approach, stations and amounts of the lymph nodes dissection were respectively the prognostic factors for DFS. However, multivariate analysis found that there was not independently factors for OS, but the tumor diameter and surgical approach were independently associated with DFS. CONCLUSION: There was no significant difference about OS between the two groups, but the RATS got better DFS. RATS got more number of the LN dissection and less blood lose. 中国肺癌杂志编辑部 2018-11-20 /pmc/articles/PMC6247004/ /pubmed/30454547 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.11.07 Text en 版权所有©《中国肺癌杂志》编辑部2018 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
title Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
title_full Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
title_fullStr Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
title_full_unstemmed Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
title_short Ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
title_sort ⅰ期非小细胞肺癌达芬奇机器人手术的疗效分析
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247004/
https://www.ncbi.nlm.nih.gov/pubmed/30454547
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.11.07
work_keys_str_mv AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī
AT iqīfēixiǎoxìbāofèiáidáfēnqíjīqìrénshǒushùdeliáoxiàofēnxī